1 Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies

2 Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls

3 A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia

4 Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 Influenza Season

5 Glycosylation of the HIV-1 Env V1V2 loop to form a native-like structure may not be essential with a nanoparticle vaccine.

6 Unveiling Integrated Functional Pathways Leading to Enhanced Respiratory Disease Associated With Inactivated Respiratory Syncytial Viral Vaccine.

7 In ovo vaccination of broilers against Campylobacter jejuni using a bacterin and subunit vaccine.

8 Silver nanoparticle-adjuvanted vaccine protects against lethal influenza infection through inducing BALT and IgA-mediated mucosal immunity.

9 Reply to "HPV vaccine requirements, opt-outs and providers' support: Key studies missing from a recent systematic review".

10 Emerging Vaccine Informatics

11 Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies – a comprehensive review

12 CONTENT REVIEW OF VACCINES AND VACCINATION RELATED NEWS IN INTERNET NEWSPAPERS

13 Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of Toxoplasma gondii in BALB/c mice

14 Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

15 Recent advances in Staphylococcus aureus infection: focus on vaccine development

16 Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach

17 A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile

18 Phenotypic and molecular characteristics of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolated from pigs: implication for livestock-association markers and vaccine strategies

19 Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease

20 Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public

21 Meningococcal conjugate vaccines: optimizing global impact

22 Review of oral cholera vaccines: efficacy in young children

23 Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease

24 Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

25 CONTENT REVIEW OF VACCINES AND VACCINATION RELATED NEWS IN INTERNET NEWSPAPERS

26 Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of Toxoplasma gondii in BALB/c mice

27 Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

28 CONTENT REVIEW OF VACCINES AND VACCINATION RELATED NEWS IN INTERNET NEWSPAPERS

29 Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of Toxoplasma gondii in BALB/c mice

30 Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

31 Immunoinformatics Approach for Multiepitopes Vaccine Prediction against Glycoprotein B of Avian Infectious Laryngotracheitis Virus

32 Recent advances in Staphylococcus aureus infection: focus on vaccine development

33 Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach

34 A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile

35 Phenotypic and molecular characteristics of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolated from pigs: implication for livestock-association markers and vaccine strategies

36 Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease

37 Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public

38 Meningococcal conjugate vaccines: optimizing global impact

39 Review of oral cholera vaccines: efficacy in young children

40 Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease

41 Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

42 Immunogenicity of a plasmid DNA vaccine encoding G1 epitope of bovine ephemeral fever virus G glycoprotein in mice

43 Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania

44 Age-appropriate vaccination coverage and its associated factors for pentavalent 1-3 and measles vaccine doses, in northeast Ethiopia: A community-based cross-sectional study.

45 Acceptability and Feasibility of Delivering Pentavalent Vaccines in a Compact, Prefilled, Autodisable Device in Vietnam and Senegal.

46 At the bench: Engineering the next generation of cancer vaccines.

47 Minipigs as a neonatal animal model for tuberculosis vaccine efficacy testing.

48 "You need to do your research": Vaccines, contestable science, and maternal epistemology.

49 Awareness, perceptions and intent to comply with the prospective malaria vaccine in parts of South Eastern Nigeria.

50 The art of partnerships for vaccines.

51 The costs of delivering vaccines in low- and middle-income countries: Findings from a systematic review.

52 A Scoping Review of Investment Cases for Vaccines and Immunization Programs.

53 Inactivated Rabies Virus-Vectored Immunocontraceptive Vaccine in a Thermo-Responsive Hydrogel Induces High and Persistent Antibodies against Rabies, but Insufficient Antibodies against Gonadotropin-Releasing Hormone for Contraception.

54 Development of a SFTSV DNA vaccine that confers complete protection against lethal infection in ferrets.

55 Development of novel subunit vaccine based on truncated fiber protein of egg drop syndrome virus and its immunogenicity in chickens.

56 Felis catus papillomavirus type 2 virus-like particle vaccine is safe and immunogenic but does not reduce FcaPV-2 viral loads in adult cats

57 The future of vaccine development.

58 AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 Region.

59 Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans.

60 A Randomized, Double-blind, Active-controlled Phase III Trial of a Cell Culture-derived Quadrivalent Inactivated Influenza Vaccine in Healthy South Korean Children and Adolescents 6 Months to 18 Years of Age.

61 Dangerous agent or saviour? HPV vaccine representations on online discussion forums in Romania.

62 Oral cholera vaccine coverage in hard-to-reach fishermen communities after two mass Campaigns, Malawi, 2016

63 A systematic review of immunogenicity, clinical efficacy and safety of human papillomavirus vaccines in people living with the human immunodeficiency virus.

64 Designing a multi-epitope based vaccine to combat Kaposi Sarcoma utilizing immunoinformatics approach

65 A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbits

66 Selective Capture and Determination of Receptor-Binding Hemagglutinin in Influenza Vaccine Preparations Using a Coupled Receptor-Binding/RP-HPLC Assay

67 Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection.

68 Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition.

69 Alginate-chitosan coated layered double hydroxide nanocomposites for enhanced oral vaccine delivery.

70 Bordetella pertussis antigens encapsulated into N-trimethyl chitosan nanoparticulate systems as a novel intranasal pertussis vaccine

71 Chitosan nano-structure loaded with recombinant E. coli O157:H7 antigens as a vaccine candidate can effectively increase immunization capacity

72 Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses

73 Determinants of Seasonal Influenza Vaccine Uptake Among the Elderly in the United States: A Systematic Review and Meta-Analysis.

74 An HRM Assay to Differentiate Sheeppox Virus Vaccine Strains from Sheeppox Virus Field Isolates and other Capripoxvirus Species

75 Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies - a comprehensive review

76 Induction of Immune Response in Animal Model Using Recombinant Anti-NDV Vaccine.

77 Current status and future prospects for the development of substance abuse vaccines.

78 Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities - Kenya, December 2013.

79 Health information technology use and influenza vaccine uptake among US adults.

80 Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.

81 MMR vaccine and suspected autism: Myths die hard

82 An attenuated Salmonella vaccine secreting Lawsonia intracellularis immunogenic antigens confers dual protection against porcine proliferative enteropathy and salmonellosis in a murine model

83 Pregnancy-related immune suppression leads to altered influenza vaccine recall responses.

84 Epidemiology of HIV-1 infection in agricultural plantation residents in Kericho, Kenya: preparation for vaccine feasibility studies.

85 Workshop report: Experimental animal models for universal influenza vaccines.

86 A pilot study of a novel, incentivised mHealth technology to monitor the vaccine supply chain in rural Zambia.

87 A Dialogic Vaccine to Bridge Opposing Cultural Viewpoints Based on Bakhtin's Views on Dialogue and Estrangement.

88 Mycobacterium 'habana' TMC 5135 as a vaccine candidate against tuberculosis: In vitro studies

89 Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.

90 Co-circulation of genetically diverse population of vaccine related and unrelated respiratory mycoplasmas and viruses in UK poultry flocks with health or production problems.

91 Effects of different vaccine combinations against Mycoplasma gallisepticum on the digestive and reproductive organ characteristics of commercial egg-laying hens.

92 Effects of different vaccine combinations against Mycoplasma gallisepticum on the internal egg and eggshell characteristics of commercial layer chickens 1,2,3.

93 A comparative study of live attenuated F strain-derived Mycoplasma gallisepticum vaccines.

94 Weighted lambda superstrings applied to vaccine design.

95 A combinatorial approach to the design of vaccines.

96 Coverage and Determinants of Uptake for Privately Funded Rotavirus Vaccine in a Canadian Birth Cohort, 2008-2013.

97 A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection.

98 Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity

99 Dengue serotype immune-interactions and their consequences for vaccine impact predictions

100 Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe.

101 Antigen Presentation Ability of Salmonella Carrying DNA Vaccine Model and MCP-3 gene

Keyword Connections

Journals

Research Groups

Bibliographies